Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

The cerebellum ages slowly according to the epigenetic clock.

Horvath S, Mah V, Lu AT, Woo JS, Choi OW, Jasinska AJ, Riancho JA, Tung S, Coles NS, Braun J, Vinters HV, Coles LS.

Aging (Albany NY). 2015 May;7(5):294-306.

2.

Whole-genome sequencing of the world's oldest people.

Gierman HJ, Fortney K, Roach JC, Coles NS, Li H, Glusman G, Markov GJ, Smith JD, Hood L, Coles LS, Kim SK.

PLoS One. 2014 Nov 12;9(11):e112430. doi: 10.1371/journal.pone.0112430. eCollection 2014.

3.

Validated worldwide supercentenarians, living and recently deceased.

Coles LS, Muir ME, Young RD.

Rejuvenation Res. 2014 Feb;17(1):80-3. doi: 10.1089/rej.2014.1553. No abstract available.

PMID:
24479945
4.

Histograms of mortality rates of validated deceased supercentenarians by month of conception and by month of death (January 1, 1970 to December 31, 2012).

Adams JM, Coles LS, Muir ME, Young RD.

Rejuvenation Res. 2013 Dec;16(6):535-6. doi: 10.1089/rej.2013.1474. No abstract available.

PMID:
23898786
5.

Interview with L. Stephen Coles, MD, PhD by Vicki Glaser.

Coles LS.

Rejuvenation Res. 2013 Jun;16(3):250-3. doi: 10.1089/rej.2013.1444. No abstract available.

PMID:
23651414
6.

Validated worldwide supercentenarians, living and recently deceased.

Coles LS.

Rejuvenation Res. 2013 Feb;16(1):82-4. doi: 10.1089/rej.2013.1411. No abstract available.

PMID:
23421869
7.

Supercentenarians and transthyretin amyloidosis: the next frontier of human life extension.

Coles LS, Young RD.

Prev Med. 2012 May;54 Suppl:S9-11. doi: 10.1016/j.ypmed.2012.03.003. No abstract available.

PMID:
22579241
8.

Functional benefits of ergothioneine and fruit- and vegetable-derived nutraceuticals: overview of the supplemental issue contents.

Aruoma OI, Coles LS, Landes B, Repine JE.

Prev Med. 2012 May;54 Suppl:S4-8. doi: 10.1016/j.ypmed.2012.04.001. Review.

PMID:
22579240
9.

Validated worldwide supercentenarians, living and recently deceased.

Coles LS.

Rejuvenation Res. 2012 Feb;15(1):113-7. doi: 10.1089/rej.2012.1320. No abstract available.

PMID:
22352439
10.

Validated worldwide supercentenarians, living and recently deceased.

Young RD, Coles LS.

Rejuvenation Res. 2011 Feb;14(1):99-104. doi: 10.1089/rej.2011.1159. No abstract available.

PMID:
21329455
11.

Living and all-time world longevity record-holders over the age of 110.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2010 Dec;13(6):759-61. doi: 10.1089/rej.2010.1145. Epub 2011 Jan 5. No abstract available.

PMID:
21208062
12.

World's oldest woman and oldest man: 1986-2010.

Young RD, Coles LS.

Rejuvenation Res. 2010 Oct;13(5):623-4. doi: 10.1089/rej.2010.1120. No abstract available.

PMID:
21142673
13.

Longest-lived humans by month of death and month of birth.

Young RD, Coles LS.

Rejuvenation Res. 2010 Aug;13(4):501-2. doi: 10.1089/rej.2010.1083. No abstract available.

PMID:
20681753
14.

Global mortality rates beyond age 110.

Young RD, Coles LS.

Rejuvenation Res. 2010 Apr-Jun;13(2-3):378-9. doi: 10.1089/rej.2010.1056. No abstract available.

PMID:
20462387
15.

Validated worldwide supercentenarians, living and recently deceased.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2010 Feb;13(1):127-32. doi: 10.1089/rej.2010.1033. No abstract available.

PMID:
20230288
16.

Validated supercentenarian cases aged 114 and above.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2009 Dec;12(6):471-3. doi: 10.1089/rej.2009.0998. No abstract available.

PMID:
20041742
17.

Supercentenarian counts by nation of birth.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2009 Oct;12(5):375-7. doi: 10.1089/rej.2009.0973. No abstract available.

PMID:
19929261
18.

Earliest validated supercentenarian by nation of birth.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2009 Aug;12(4):301-2. doi: 10.1089/rej.2009.0912. No abstract available.

PMID:
19827959
19.

Living and all-time world longevity record-holders over the age of 110.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2009 Jun;12(3):231-2. doi: 10.1089/rej.2009.0882. No abstract available.

PMID:
19594333
20.

Global mortality rates beyond age 110.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2009 Apr;12(2):159-60. doi: 10.1089/rej.2009.0857. No abstract available.

PMID:
19419246
21.

Validated worldwide supercentenarians, living and recently deceased.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2009 Feb;12(1):65-8. doi: 10.1089/rej.2009.0835. No abstract available.

PMID:
19207014
22.

Supercentenarians Table: validated supercentenarian cases aged 114 and above.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2008 Dec;11(6):1083-5. doi: 10.1089/rej.2008.0821. No abstract available.

PMID:
19119865
23.

Supercentenarian counts by nation of birth.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2008 Oct;11(5):981-3. doi: 10.1089/rej.2008.0801. No abstract available.

PMID:
18928427
24.

Supercentenarians table: earliest validated supercentenarian by nation of birth.

Young RD, Epstein L, Coles LS.

Rejuvenation Res. 2008 Aug;11(4):851-2. doi: 10.1089/rej.2008.0777. No abstract available.

PMID:
18729820
25.

Living and all-time world longevity record holders over the age of 110.

Coles LS.

Rejuvenation Res. 2008 Jun;11(3):707-8. doi: 10.1089/rej.2008.0744. No abstract available.

PMID:
18593292
26.

Validated worldwide supercentenarians, living and recently deceased.

Coles LS.

Rejuvenation Res. 2008 Feb;11(1):269-72. doi: 10.1089/rej.2008.0695. No abstract available.

PMID:
18257659
27.

Validated supercentenarian cases aged 114 and above.

Coles LS.

Rejuvenation Res. 2007 Dec;10(4):657-8. No abstract available.

PMID:
18072885
28.

Validated supercentenarian cases aged 114 and above.

Coles LS; Los Angeles Gerontology Research Group (LA-GRG).

Rejuvenation Res. 2006 Winter;9(4):503-5. No abstract available.

PMID:
17105392
29.

DNA binding-independent transcriptional activation of the vascular endothelial growth factor gene (VEGF) by the Myb oncoprotein.

Lutwyche JK, Keough RA, Hunter J, Coles LS, Gonda TJ.

Biochem Biophys Res Commun. 2006 Jun 16;344(4):1300-7. Epub 2006 Apr 24.

PMID:
16650815
30.

Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter.

Coles LS, Lambrusco L, Burrows J, Hunter J, Diamond P, Bert AG, Vadas MA, Goodall GJ.

FEBS Lett. 2005 Oct 10;579(24):5372-8. Epub 2005 Sep 20.

31.

Validated worldwide supercentenarians for 2004.

Coles LS.

Rejuvenation Res. 2005 Spring;8(1):69-71. No abstract available.

PMID:
15798378
32.

Validated supercentenarian cases aged 114 and above.

Coles LS; Los Angeles Gerontology Research Group (LA-GRG).

Rejuvenation Res. 2004 Winter;7(4):271-3. Review. No abstract available.

PMID:
15671732
33.

Demographics of human supercentenarians and the implications for longevity medicine.

Coles LS.

Ann N Y Acad Sci. 2004 Jun;1019:490-5. Review.

PMID:
15247072
34.

Demography of human supercentenarians.

Coles LS.

J Gerontol A Biol Sci Med Sci. 2004 Jun;59(6):B579-86.

PMID:
15215268
35.

Table of world-wide living supercentenarians.

Coles LS.

J Anti Aging Med. 2003;6(4):357-60. No abstract available.

PMID:
15142437
36.

Table of world-wide living supercentenarians.

Coles LS.

J Anti Aging Med. 2003;6(3):275-8. No abstract available.

PMID:
14987438
37.
38.

Table of world-wide living supercentenarians.

Coles LS.

J Anti Aging Med. 2003 Spring;6(1):65-8. No abstract available.

PMID:
12941183
39.

A novel mechanism of repression of the vascular endothelial growth factor promoter, by single strand DNA binding cold shock domain (Y-box) proteins in normoxic fibroblasts.

Coles LS, Diamond P, Lambrusco L, Hunter J, Burrows J, Vadas MA, Goodall GJ.

Nucleic Acids Res. 2002 Nov 15;30(22):4845-54.

41.

Antiaging technology and pseudoscience.

de Grey AD, Gavrilov L, Olshansky SJ, Coles LS, Cutler RG, Fossel M, Harman SM.

Science. 2002 Apr 26;296(5568):656. No abstract available.

PMID:
11985356
42.

RNA destabilization by the granulocyte colony-stimulating factor stem-loop destabilizing element involves a single stem-loop that promotes deadenylation.

Putland RA, Sassinis TA, Harvey JS, Diamond P, Coles LS, Brown CY, Goodall GJ.

Mol Cell Biol. 2002 Mar;22(6):1664-73.

43.

The role of architectural transcription factors in cytokine gene transcription.

Shannon MF, Coles LS, Attema J, Diamond P.

J Leukoc Biol. 2001 Jan;69(1):21-32. Review.

PMID:
11200063
44.

Cold shock domain factors activate the granulocyte-macrophage colony-stimulating factor promoter in stimulated Jurkat T cells.

Diamond P, Shannon MF, Vadas MA, Coles LS.

J Biol Chem. 2001 Mar 16;276(11):7943-51. Epub 2000 Dec 14.

45.
46.

Signals for activation of the GM-CSF promoter and enhancer in T cells.

Shannon MF, Coles LS, Vadas MA, Cockerill PN.

Crit Rev Immunol. 1997;17(3-4):301-23. Review.

PMID:
9202885
48.

Cold shock domain proteins repress transcription from the GM-CSF promoter.

Coles LS, Diamond P, Occhiodoro F, Vadas MA, Shannon MF.

Nucleic Acids Res. 1996 Jun 15;24(12):2311-7.

49.

GM-CSF and IL-2 share common control mechanisms in response to costimulatory signals in T cells.

Shannon MF, Himes SR, Coles LS.

J Leukoc Biol. 1995 May;57(5):767-73. Review.

PMID:
7759956
50.

A sequence-specific single-strand DNA binding protein that contacts repressor sequences in the human GM-CSF promoter.

Coles LS, Occhiodoro F, Vadas MA, Shannon MF.

Nucleic Acids Res. 1994 Oct 11;22(20):4276-83.

Supplemental Content

Loading ...
Support Center